糖化アルブミンの世界市場2020-2026:糖化アルブミン(ヒト)、糖化アルブミン(動物)

QYResearchが発行した調査報告書(QYR20AP06274)
◆英語タイトル:Global Glycated Albumin Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP06274
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:112
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,600 ⇒換算¥828,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD8,400 ⇒換算¥1,243,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD11,200 ⇒換算¥1,657,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、糖化アルブミンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、糖化アルブミンのグローバル市場動向、主要メーカー別の市場シェア、種類別市場規模(糖化アルブミン(ヒト)、糖化アルブミン(動物))、用途別市場規模(病院&診療所、研究所)、地域別(北米、ヨーロッパ、中国、日本)生産規模、地域別(北米、ヨーロッパ、アジア、中南米、中東・アフリカ)消費規模、バリューチェーン、販売チャネル、市場機会・課題・市場環境分析、関連企業情報などを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別市場シェア
・糖化アルブミンの種類別市場予測2015-2026:糖化アルブミン(ヒト)、糖化アルブミン(動物)
・糖化アルブミンの用途別市場予測2015-2026:病院&診療所、研究所
・糖化アルブミンの地域別生産規模2015-2026:北米、ヨーロッパ、中国、日本
・糖化アルブミンの地域別消費規模2015-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・関連企業情報:Asahi Kasei Pharma、DIAZYME、Abnova、LifeSpan、Exocell、BSBE、Medicalsystem、Maccura、Leadman、Simes Sikma、NINGBO PUREBIO
・糖化アルブミンの地域別生産規模予測2021-2026:北米、ヨーロッパ、中国、日本
・糖化アルブミンの地域別消費規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・バリューチェーン及び販売チャネル分析
・市場機会・課題・市場環境分析
・結論
【レポートの概要】

Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy.
Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose present in diabetes meatus results in increased glycation of all proteins, including, albumin. Measurement of the amount of the glycation reaction resulting from the combination of glucose with free amino groups in proteins present in the blood is used to monitor the level of glucose that has generally been present in body fluids over a preceding period.

Thus serum glycated albumin assay can be used to determine the current level of glycation of albumin, the most abundant plasma protein. Hence, the gycated albumin assay may be used as a marker of glycemic control in diabetes and reflects glycemic control over the precious 2 to 4 weeks.
Glycated albumin industry is relatively concentrated, manufacturers are mostly in the Europe, North America, Japan and China. Among them, Japan output value accounted for more than 81.90% of the total output value of global glycated albumin. Asahi Kasei Pharma is the world leading manufacturer in global glycated albumin market with the market share of 79.81% in 2015, in terms of revenue.
The Glycated Albumin market was valued at US$ 377 Million in 2019 and is projected to reach US$ 528.9 Million by 2026, at a CAGR of 4.9% during the forecast period. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Glycated Albumin.

In terms of production side, this report researches the Glycated Albumin capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Glycated Albumin by regions (countries) and application.
The global Glycated Albumin market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Glycated Albumin market. These figures have been provided in terms of both revenue and volume for the period 2015-2026. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Glycated Albumin markets such as the U.S., Canada, Germany, France, the U.K., Italy, Russia, China, Japan, South Korea, Taiwan, India, the Philippines, Malaysia, Thailand, Indonesia, Vietnam Australia, Mexico, Brazil, Saudi Arabia, the UAE and Turkey etc. Key regions covered in the report are North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
For the period 2015-2026, the report provides country-wise revenue and production capacity analysis and region-wise revenue and volume analysis of the global Glycated Albumin market. For the period 2015-2020, it provides consumption (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation
The report includes a detailed analysis of leading and by Type and by Application segments of the global Glycated Albumin market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers value, volume analysis and forecast of the global Glycated Albumin market by Type and by Application segment for the period 2015-2026.
Segment by Type, the Glycated Albumin market is segmented into
Glycated Albumin (Human)
Glycated Albumin (Animal)

Segment by Application, the Glycated Albumin market is segmented into
Hospitals and Clinics
Laboratories
Competitive Landscape and Glycated Albumin Market Share Analysis
Glycated Albumin market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, revenue and price by the player for the period 2015-2020. Details included are company description, major businesses, company total revenue and the production capacity, revenue generated in Glycated Albumin business, competitors, the date to enter into the Glycated Albumin market, Glycated Albumin product introduction, recent developments, etc.

The major vendors covered:
Asahi Kasei Pharma
DIAZYME
Abnova
LifeSpan
Exocell
BSBE
Medicalsystem
Maccura
Leadman
Simes Sikma
NINGBO PUREBIO

The study objectives are:
To analyze and research the global Glycated Albumin status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Glycated Albumin manufacturers, capacity, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and application.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Glycated Albumin are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Glycated Albumin Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Glycated Albumin Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Glycated Albumin (Human)
1.3.3 Glycated Albumin (Animal)
1.4 Market Segment by Application
1.4.1 Global Glycated Albumin Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospitals and Clinics
1.4.3 Laboratories
1.5 Study Objectives
1.6 Years Considered

2 Global Market Perspective
2.1 Global Glycated Albumin Production Capacity Analysis
2.1.1 Global Glycated Albumin Production Value (2015-2026)
2.1.2 Global Glycated Albumin Production (2015-2026)
2.1.3 Global Glycated Albumin Capacity (2015-2026)
2.1.4 Global Glycated Albumin Marketing Pricing and Trends
2.2 Global Glycated Albumin Market Size Growth Potential by Key Producing Regions
2.2.1 Global Glycated Albumin Market Size by Key Producing Regions: 2015 VS 2021 VS 2026
2.2.2 Global Glycated Albumin Market Share by Key Producing Regions: 2021 VS 2026
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Primary Interviews with Key Glycated Albumin Players: Views for Future

3 Market Share by Manufacturers
3.1 Global Top Manufacturers by Glycated Albumin Production Capacity
3.1.1 Global Top Manufacturers by Glycated Albumin Production Capacity (2015-2020)
3.1.2 Global Top Manufacturers by Glycated Albumin Production (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Glycated Albumin Production in 2019
3.2 Global Top Manufacturers by Glycated Albumin Revenue
3.2.1 Global Top Manufacturers by Glycated Albumin Revenue (2015-2020)
3.2.2 Global Top Manufacturers Market Share by Glycated Albumin Revenue (2015-2020)
3.2.3 Global Glycated Albumin Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glycated Albumin as of 2019)
3.4 Global Glycated Albumin Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Glycated Albumin Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Glycated Albumin Market
3.7 Key Manufacturers Glycated Albumin Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Estimate and Forecast by Type (2015-2026)
4.1 Global Glycated Albumin Historic Market Size by Type (2015-2020)
4.1.2 Global Glycated Albumin Production Market Share by Type (2015-2020)
4.1.3 Global Glycated Albumin Production Value Market Share by Type
4.1.4 Glycated Albumin Average Selling Price (ASP) by Type (2015-2020)
4.2 Global Glycated Albumin Market Size Forecast by Type (2021-2026)
4.2.2 Global Glycated Albumin Production Market Share Forecast by Type (2021-2026)
4.2.3 Global Glycated Albumin Production Value Market Share Forecast by Type
4.2.4 Glycated Albumin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Glycated Albumin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Glycated Albumin Consumption by Application (2015-2020)
5.2 Global Glycated Albumin Consumption by Application (2021-2026)

6 Production by Regions: Market Fact & Figures
6.1 Global Glycated Albumin Production (History Data) by Regions (2015-2020)
6.2 Global Glycated Albumin Production Value (History Data) by Regions
6.3 North America
6.3.1 North America Glycated Albumin Production Growth Rate (2015-2020)
6.3.2 North America Glycated Albumin Production Value Growth Rate (2015-2020)
6.3.3 Key Players Market Share in North America
6.3.4 North America Glycated Albumin Import & Export (2015-2020)
6.4 Europe
6.4.1 Europe Glycated Albumin Production Growth Rate (2015-2020)
6.4.2 Europe Glycated Albumin Production Value Growth Rate (2015-2020)
6.4.3 Key Players Market Share in Europe
6.4.4 Europe Glycated Albumin Import & Export (2015-2020)
6.5 China
6.5.1 China Glycated Albumin Production Growth Rate (2015-2020)
6.5.2 China Glycated Albumin Production Value Growth Rate (2015-2020)
6.5.3 Key Players Market Share in China
6.5.4 China Glycated Albumin Import & Export (2015-2020)
6.6 Japan
6.6.1 Japan Glycated Albumin Production Growth Rate (2015-2020)
6.6.2 Japan Glycated Albumin Production Value Growth Rate (2015-2020)
6.6.3 Key Players Market Share in Japan
6.6.4 Japan Glycated Albumin Import & Export (2015-2020)

7 Glycated Albumin Consumption by Regions: Market Fact & Figures
7.1 Global Glycated Albumin Consumption (History Data) by Regions (2015-2020)
7.2 Global Top Glycated Albumin Consumers (regions/countries) Ranking and Share of Total Glycated Albumin Consumption in 2015 VS 2019
7.3 North America
7.3.1 North America Glycated Albumin Consumption by Type
7.3.2 North America Glycated Albumin Consumption by Application
7.3.3 North America Glycated Albumin Consumption by Countries
7.3.4 U.S.
7.3.5 Canada
7.4 Europe
7.4.1 Europe Glycated Albumin Consumption by Type
7.4.2 Europe Glycated Albumin Consumption by Application
7.4.3 Europe Glycated Albumin Consumption by Countries
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
7.5 Asia Pacific
7.5.1 Asia Pacific Glycated Albumin Consumption by Type
7.5.2 Asia Pacific Glycated Albumin Consumption by Application
7.5.3 Asia Pacific Glycated Albumin Consumption by Regions
7.5.4 China
7.5.5 Japan
7.5.6 South Korea
7.5.7 India
7.5.8 Australia
7.5.9 Taiwan
7.5.10 Indonesia
7.5.11 Thailand
7.5.12 Malaysia
7.5.13 Philippines
7.5.14 Vietnam
7.6 Central & South America
7.6.1 Central & South America Glycated Albumin Consumption by Type
7.6.2 Central & South America Glycated Albumin Consumption by Application
7.6.3 Central & South America Glycated Albumin Consumption by Countries
7.6.4 Mexico
7.6.5 Brazil
7.6.6 Argentina
7.7 Middle East and Africa
7.7.1 Middle East and Africa Glycated Albumin Consumption by Type
7.7.2 Middle East and Africa Glycated Albumin Consumption by Application
7.7.3 Central & South America Glycated Albumin Consumption by Countries
7.7.4 Turkey
7.7.5 Saudi Arabia
7.7.6 U.A.E

8 Company Profiles
8.1 Asahi Kasei Pharma
8.1.1 Asahi Kasei Pharma Corporation Information
8.1.2 Asahi Kasei Pharma Business Overview and Total Revenue (2019 VS 2018)
8.1.3 Asahi Kasei Pharma Glycated Albumin Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.1.4 Glycated Albumin Products and Services
8.1.5 Asahi Kasei Pharma SWOT Analysis
8.1.6 Asahi Kasei Pharma Recent Developments
8.2 DIAZYME
8.2.1 DIAZYME Corporation Information
8.2.2 DIAZYME Business Overview and Total Revenue (2019 VS 2018)
8.2.3 DIAZYME Glycated Albumin Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.2.4 Glycated Albumin Products and Services
8.2.5 DIAZYME SWOT Analysis
8.2.6 DIAZYME Recent Developments
8.3 Abnova
8.3.1 Abnova Corporation Information
8.3.2 Abnova Business Overview and Total Revenue (2019 VS 2018)
8.3.3 Abnova Glycated Albumin Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.3.4 Glycated Albumin Products and Services
8.3.5 Abnova SWOT Analysis
8.3.6 Abnova Recent Developments
8.4 LifeSpan
8.4.1 LifeSpan Corporation Information
8.4.2 LifeSpan Business Overview and Total Revenue (2019 VS 2018)
8.4.3 LifeSpan Glycated Albumin Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.4.4 Glycated Albumin Products and Services
8.4.5 LifeSpan SWOT Analysis
8.4.6 LifeSpan Recent Developments
8.5 Exocell
8.5.1 Exocell Corporation Information
8.5.2 Exocell Business Overview and Total Revenue (2019 VS 2018)
8.5.3 Exocell Glycated Albumin Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.5.4 Glycated Albumin Products and Services
8.5.5 Exocell SWOT Analysis
8.5.6 Exocell Recent Developments
8.6 BSBE
8.6.1 BSBE Corporation Information
8.6.3 BSBE Glycated Albumin Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.6.3 BSBE Glycated Albumin Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.6.4 Glycated Albumin Products and Services
8.6.5 BSBE SWOT Analysis
8.6.6 BSBE Recent Developments
8.7 Medicalsystem
8.7.1 Medicalsystem Corporation Information
8.7.2 Medicalsystem Business Overview and Total Revenue (2019 VS 2018)
8.7.3 Medicalsystem Glycated Albumin Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.7.4 Glycated Albumin Products and Services
8.7.5 Medicalsystem SWOT Analysis
8.7.6 Medicalsystem Recent Developments
8.8 Maccura
8.8.1 Maccura Corporation Information
8.8.2 Maccura Business Overview and Total Revenue (2019 VS 2018)
8.8.3 Maccura Glycated Albumin Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.8.4 Glycated Albumin Products and Services
8.8.5 Maccura SWOT Analysis
8.8.6 Maccura Recent Developments
8.9 Leadman
8.9.1 Leadman Corporation Information
8.9.2 Leadman Business Overview and Total Revenue (2019 VS 2018)
8.9.3 Leadman Glycated Albumin Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.9.4 Glycated Albumin Products and Services
8.9.5 Leadman SWOT Analysis
8.9.6 Leadman Recent Developments
8.10 Simes Sikma
8.10.1 Simes Sikma Corporation Information
8.10.2 Simes Sikma Business Overview and Total Revenue (2019 VS 2018)
8.10.3 Simes Sikma Glycated Albumin Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.10.4 Glycated Albumin Products and Services
8.10.5 Simes Sikma SWOT Analysis
8.10.6 Simes Sikma Recent Developments
8.11 NINGBO PUREBIO
8.11.1 NINGBO PUREBIO Corporation Information
8.11.2 NINGBO PUREBIO Business Overview and Total Revenue (2019 VS 2018)
8.11.3 NINGBO PUREBIO Glycated Albumin Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.11.4 Glycated Albumin Products and Services
8.11.5 NINGBO PUREBIO SWOT Analysis
8.11.6 NINGBO PUREBIO Recent Developments

9 Glycated Albumin Production Side by Producing Regions (Countries)
9.1 Global Glycated Albumin Production Value Forecast by Region (2021-2026)
9.2 Glycated Albumin Production Forecast by Regions
9.3 Key Glycated Albumin Producing Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan

10 Glycated Albumin Consumption Forecast by Top Consumers (Regions/Countries)
10.1 Global Glycated Albumin Consumption Forecast by Region (2021-2026)
10.2 North America Market Consumption YoY Growth Forecast
10.2.1 North America Glycated Albumin Consumption YoY Growth (2021-2026)
10.2.2 North America Glycated Albumin Consumption Forecast by Country (2021-2026)
10.3 Europe Market Consumption YoY Growth Forecast
10.3.1 Europe Glycated Albumin Consumption YoY Growth (2021-2026)
10.3.2 Europe Glycated Albumin Consumption Forecast by Country (2021-2026)
10.4 Asia Pacific Market Consumption YoY Growth Forecast
10.4.1 Asia Pacific Glycated Albumin Consumption YoY Growth (2021-2026)
10.4.1 Asia Pacific Glycated Albumin Consumption Forecast by Regions (2021-2026)
10.5 Latin America Market Consumption YoY Growth Forecast
10.5.1 Latin America Glycated Albumin Consumption YoY Growth (2021-2026)
10.5.2 Latin America Glycated Albumin Consumption Forecast by Country (2021-2026)
10.6 Middle East and Africa Market Consumption YoY Growth Forecast
10.6.1 Middle East and Africa Glycated Albumin Consumption YoY Growth (2021-2026)
10.6.2 Middle East and Africa Glycated Albumin Consumption Forecast by Country (2021-2026)

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Glycated Albumin Sales Channels
11.2.2 Glycated Albumin Distributors
11.3 Glycated Albumin Customers

12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis

13 Key Findings

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

...

【掲載企業】

Asahi Kasei Pharma、DIAZYME、Abnova、LifeSpan、Exocell、BSBE、Medicalsystem、Maccura、Leadman、Simes Sikma、NINGBO PUREBIO

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 糖化アルブミンの世界市場2020-2026:糖化アルブミン(ヒト)、糖化アルブミン(動物)(Global Glycated Albumin Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。